Results 171 to 180 of about 101,700 (245)

Targeting tumor dormancy: the next frontier in gastrointestinal stromal tumor therapy. [PDF]

Neoplasia
Wu S, Liu H, Yin Y, Li J, Zhang Z, Li W, Fu Y.   +6 more
europepmc   +1 more source

A giant gastrointestinal stromal tumour mimicking gastric diverticulum: a case report. [PDF]

J Surg Case Rep
Mainali SK, Regmi J, Shrestha UM, Kansakar R, Shakya M.   +4 more
europepmc   +1 more source

Impact of neoadjuvant imatinib duration and tumor response on recurrence-free survival in locally advanced gastrointestinal stromal tumors: a retrospective multicenter cohort study. [PDF]

World J Surg Oncol
Zong H, Kou Y, Song H, Lan Z, Mu Y, Xiao Q, Jin X, Li Y, Xiang S, Huo Y, Zhou M, Zhang X, Wu X, Zhang J.   +13 more
europepmc   +1 more source

Design, Synthesis, and Biological Evaluation of <i>N</i>,<i>N</i>-Diphenylaniline-Based Derivatives as Antiproliferative Agents and ABL TK Inhibitors Against CML. [PDF]

Pharmaceuticals (Basel)
Sever B, Ciftci H.
europepmc   +1 more source

Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design. [PDF]

Circulation
Jambon-Barbara C, Suissa S, Dell'Aniello S, Hlavaty A, Cracowski JL, Chaumais MC, Humbert M, Montani D, Khouri C.   +8 more
europepmc   +1 more source

Management of locally-advanced dermatofibrosarcoma protuberans: Four cases report. [PDF]

Medicine (Baltimore)
Zhang H, Zhang L, Wang H.
europepmc   +1 more source

LIN28A-Dependent Kinome and Phosphoproteome Reprogramming Promotes Imatinib Resistance. [PDF]

Mol Cell Proteomics
Hovey OFJ, Frederick MI, Quach QM, Kakadia JH, Wu A, Yang K, Wu T, Ruan X, Kaneko T, Voss C, Heinemann IU, Li SSC.   +11 more
europepmc   +1 more source

Age and gender effects on molecular responses in chronic myeloid leukemia patients by first-line treatment: an Italian CML network cohort study. [PDF]

Ann Hematol
Breccia M, Giai V, Rosso T, Pregno P, Castagnetti F, Bonifacio M, Capodanno I, Tiribelli M, Stagno F, Caocci G, Gozzini A, Patriarca A, Sorà F, Loglisci G, Rossi AR, Coppi MR, Miggiano MC, Di Raimondo F, Galimberti S, Rosti G, Melillo L, Pane F, Saglio G, Ciccone G, Specchia G.   +24 more
europepmc   +1 more source

Dynamics of <i>BCR::ABL1</i> transcript levels and clinical outcomes after switch to second-line therapy in pediatric chronic myeloid leukemia. [PDF]

Hemasphere
Sembill S, Zerjatke T, Winterstein M, Ghete T, Schirmer E, Wotschofsky Z, Suttorp M, Krumbholz M, Karow A, Glauche I, Metzler M.   +10 more
europepmc   +1 more source

KIT Mutation-NTRK fusion oncogenic driver switch: a novel mechanism of acquired imatinib resistance in GIST. [PDF]

NPJ Precis Oncol
Gloazzo S, Sbaraglia M, Bellan E, Gasparotto D, Belli E, Baldazzi D, Rossi G, Magnani E, Rosito MP, Carnevali A, Piccinin S, Dei Tos AP, Maestro R.   +12 more
europepmc   +1 more source